Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Key findings at the highest dose (12mg weekly): Up to 24% mean body weight reduction over 48 weeks Significant reductions in fasting glucose and insulin resistance markers Meaningful reductions in liver fat content, relevant for participants with metabolic-associated fatty liver disease Once-weekly subcutaneous dosing was generally well-tolerated For context, semaglutide at its approved dose achieves approximately 1517% body weight reduction over 68 weeks
At a franchise chair, the person across from you opens with a monthly payment, a package deal, and a guarantee of how many sessions you will need
Some people might also experience increased anxiety or jitteriness, especially in the early stages of treatment
User 41 reported severe anxiety, bloating, headaches, and gut pain after oral BPC-157 use
